找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Hepatocellular Carcinoma:; Targeted Therapy and Kelly M. McMasters Book 2011 Springer Science+Business Media, LLC 2011 Bead Therapy.HCC.Int

[复制链接]
楼主: exposulate
发表于 2025-3-25 05:29:47 | 显示全部楼层
Microwave Ablation and Hepatocellular Carcinoma,Hepatocellular carcinoma remains one of the most common malignant neoplasms and is responsible for greater than one million deaths per year [1]. Prognosis of HCC is exceedingly poor because of the high malignancy biology, high recurrence, and overall resistance to current therapies [2].
发表于 2025-3-25 09:49:17 | 显示全部楼层
Kelly M. McMastersNew targeted therapeutic procedures.Advanced surgical procedures.New investigational treatment options
发表于 2025-3-25 12:08:54 | 显示全部楼层
发表于 2025-3-25 17:02:58 | 显示全部楼层
发表于 2025-3-25 22:32:48 | 显示全部楼层
Hepatocellular Cancer: Pathologic Considerations,f HCCs, including their pattern of spread, the risk factors for recurrence, and long-term prognosis. More particularly, a focus of great interest has been the diagnosis of early HCC. Understanding by histopathologists, surgeons, hepatologists, and oncologists of the nuances of the diagnosis of early
发表于 2025-3-26 01:11:36 | 显示全部楼层
发表于 2025-3-26 04:50:20 | 显示全部楼层
发表于 2025-3-26 09:26:32 | 显示全部楼层
发表于 2025-3-26 13:31:49 | 显示全部楼层
发表于 2025-3-26 17:15:38 | 显示全部楼层
Liver Resection for Hepatocellular Carcinoma,ts with early stages, the prognosis is poor if the disease is left untreated [1, 2]. As primary medical therapy has failed to significantly improve survival, surgical resection and orthotopic liver transplantation (OLT) represent the only treatment options offering a prospect for cure with 5-year su
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 09:25
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表